These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23721110)

  • 1. Case studies of innovative medical device companies from India: barriers and enablers to development.
    Jarosławski S; Saberwal G
    BMC Health Serv Res; 2013 May; 13():199. PubMed ID: 23721110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical equipment industry in India: Production, procurement and utilization.
    Chakravarthi I
    Indian J Public Health; 2013; 57(4):203-7. PubMed ID: 24351379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategic management and organizational culture of medical device companies in relation to corporate performance.
    Park S; Kim HK; Lee HJ; Choi M; Lee M; Jakovljevic M
    J Med Econ; 2023; 26(1):781-792. PubMed ID: 37300440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invention and business performance in the tissue-engineering industry.
    Pangarkar N; Hutmacher DW
    Tissue Eng; 2003 Dec; 9(6):1313-22. PubMed ID: 14670118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results from an exploratory study to identify the factors that contribute to success for UK medical device small- and medium-sized enterprises.
    Hourd PC; Williams DJ
    Proc Inst Mech Eng H; 2008 Jul; 222(5):717-35. PubMed ID: 18756690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulating the private health care sector: the case of the Indian Consumer Protection Act.
    Bhat R
    Health Policy Plan; 1996 Sep; 11(3):265-79. PubMed ID: 10160372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of health biotechnology in developing countries: can private-sector players be the prime movers?
    Abuduxike G; Aljunid SM
    Biotechnol Adv; 2012; 30(6):1589-601. PubMed ID: 22617902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Market entry and exit by biotech and device companies funded by venture capital.
    Burns LR; Housman MG; Robinson CA
    Health Aff (Millwood); 2009; 28(1):w76-86. PubMed ID: 19049998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practices of the best companies in the medical industry.
    Atherton E; Kleiner BH
    Int J Health Care Qual Assur Inc Leadersh Health Serv; 1998; 11(4-5):173-6. PubMed ID: 10185331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. India-EU relations in health services: prospects and challenges.
    Chanda R
    Global Health; 2011 Feb; 7():1. PubMed ID: 21310041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. District decision-making for health in low-income settings: a case study of the potential of public and private sector data in India and Ethiopia.
    Bhattacharyya S; Berhanu D; Taddesse N; Srivastava A; Wickremasinghe D; Schellenberg J; Iqbal Avan B
    Health Policy Plan; 2016 Sep; 31 Suppl 2(Suppl 2):ii25-ii34. PubMed ID: 27591203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of private medical practice in India: a provider perspective.
    Bhat R
    Health Policy Plan; 1999 Mar; 14(1):26-37. PubMed ID: 10351467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introducing new contraceptives.
    Segal SJ; Coutinho E
    Draper Fund Rep; 1986 Dec; (15):27-32. PubMed ID: 12341234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing innovation between scientific and indigenous knowledge: pioneer NGOs in India.
    Torri MC; Laplante J
    J Ethnobiol Ethnomed; 2009 Oct; 5():29. PubMed ID: 19849851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indian Biotech Bazaar: a swot analysis.
    Kumar A
    Biotechnol J; 2007 May; 2(5):543-5. PubMed ID: 17479978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.